AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review

Immunoglobulin light chain (AL) amyloidosis is an incurable plasma cell disorder characterized by deposition of fibrils of misfolded immunoglobulin free light chains (FLC) in target organs, leading to failure. Cardiac involvement is common in AL amyloidosis and represents the single most adverse pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianchi, Giada, Zhang, Yifei, Comenzo, Raymond L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543128/
https://www.ncbi.nlm.nih.gov/pubmed/34729520
http://dx.doi.org/10.1016/j.jaccao.2021.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543128/
https://www.ncbi.nlm.nih.gov/pubmed/34729520
http://dx.doi.org/10.1016/j.jaccao.2021.09.003

Ejemplares similares